Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Schaefer

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Inherited Metabolic Disease|July 18, 2002
A new case of CDG-x with stereotyped dystonic hand movements and optic atrophyV Prietsch, V Peters, R Hackler, et al.
Atherosclerosis|April 27, 2000
HDL steady state levels are not affected, but HDL apoA-I turnover is enhanced by Lifibrol in patients with hypercholesterolemia and mixed hyperlipidemiaK Winkler, J R Schaefer, B Klima, et al.
Neuropediatrics|April 4, 2002
Congenital disorder of glycosylation IId (CDG-IId) -- a new entity: clinical presentation with Dandy-Walker malformation and myopathyV Peters, J M Penzien, G Reiter, et al.
Metabolism: Clinical and Experimental|November 1, 1993
Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemiaD J Rader, J R Schaefer, P Lohse, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 11, 1992
In vivo metabolism of apolipoprotein A-I in a patient with homozygous familial hypercholesterolemiaJ R Schaefer, D J Rader, K Ikewaki, et al.
Circulation|December 19, 2001
Low hepatic lipase activity is a novel risk factor for coronary artery diseaseK A Dugi, K Brandauer, N Schmidt, et al.
Der Internist|April 29, 2014
[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology]G Klose, F U Beil, H Dieplinger, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Inherited Metabolic Disease|July 18, 2002
A new case of CDG-x with stereotyped dystonic hand movements and optic atrophyV Prietsch, V Peters, R Hackler, et al.
Atherosclerosis|April 27, 2000
HDL steady state levels are not affected, but HDL apoA-I turnover is enhanced by Lifibrol in patients with hypercholesterolemia and mixed hyperlipidemiaK Winkler, J R Schaefer, B Klima, et al.
Neuropediatrics|April 4, 2002
Congenital disorder of glycosylation IId (CDG-IId) -- a new entity: clinical presentation with Dandy-Walker malformation and myopathyV Peters, J M Penzien, G Reiter, et al.
Metabolism: Clinical and Experimental|November 1, 1993
Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemiaD J Rader, J R Schaefer, P Lohse, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 11, 1992
In vivo metabolism of apolipoprotein A-I in a patient with homozygous familial hypercholesterolemiaJ R Schaefer, D J Rader, K Ikewaki, et al.
Circulation|December 19, 2001
Low hepatic lipase activity is a novel risk factor for coronary artery diseaseK A Dugi, K Brandauer, N Schmidt, et al.
Der Internist|April 29, 2014
[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology]G Klose, F U Beil, H Dieplinger, et al.
Pageof 5